Stem Cell Therapy Used for Inflammation Shows Promise for Improving Cognitive Function After Brain Injury

A stem cell therapy traditionally used to reduce inflammation after traumatic brain injury has been shown to contribute to long-term cognitive improvement. The research, published in STEM CELLS Translational Medicine, was conducted at the University of Texas Health Science Center at Houston Medical School.  A stem cell therapy called mulitpotent adult progenitor cell (MAPC) had been used to reduce neurological inflammation in mice. After four months, mice receiving stronger doses made notable gains in cognitive function.  Researchers are hopeful that the intravenous injection of MAPCs may be beneficial in effectively treating people with brain injury. Click here to read more.